Vipul Jairath
University of Western Ontario
311 Papers
250 Citations
Vipul Jairath is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 35, co-authored 88 publications. Previous affiliations of Vipul Jairath include NHS Blood and Transplant & University of Oxford.
Chat about Author
Papers
Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis.
Sudheer K. Vuyyuru,Virginia Solitano,M. Hogan,John K MacDonald,Claire E Parker,Bruce E. Sands,Remo Panaccione,Neeraj Narula,Brian G. Feagan,Siddharth Singh,Vipul Jairath,Christopher Ma +11 more
TL;DR: Targeting IL-23 is effective and safe for inducing and maintaining clinical and endoscopic remission in patients with moderate-to-severe CD.
8
Immunotherapy for Cancer: Common Gastrointestinal, Liver, and Pancreatic Side Effects and Their Management
Rocio Sedano,Daniel Cabrera,Andrea Jiménez,Christopher Ma,Vipul Jairath,Marco Arrese,Juan Pablo Arab +6 more
TL;DR: The use of immune checkpoint inhibitors (ICI) has been successful for cancer types that do not respond well to conventional chemotherapy, showing clinical benefit in various advanced and metastatic cancers and supporting the promise of cancer immunotherapy as mentioned in this paper .
8
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy.
TL;DR: Routine screening for HDV in hepatitis B virusinfected patients and the general population is not presently supported by available evidence, although future research will be required to further define key at-risk populations for whom risk factor-based testing may be indicated.
8
Scoring indices for perianal fistulizing Crohn's disease: A systematic review.
S. Vuyyuru,Virginia Solitano,Siddharth Singh,Jurij Hanzel,John K Macdonald,S. Danese,Laurent Peyrin Biroulet,Christopher Ma,Vipul Jairath +8 more
TL;DR: There are no fully valid, reliable, and responsive clinical disease or radiological indices for PFCD and well-defined cut-offs for response and remission are lacking.
7
W1038 Acute Upper Gastrointestinal Bleeding – Why Do Patients Die?
Vipul Jairath,Richard F A Logan,S A Hearnshaw,Simon Travis,Michael F. Murphy,Kelvin R. Palmer +5 more
TL;DR: The majority of patients admitted with AUGIB did not die from further bleeding, but rather from another cause, and there was no significant difference in use of NSAIDS in those who died of a bleeding vs non-bleeding cause.
7